Toggle light / dark theme

Spontaneous Emergence of Self-Replicating Molecules Containing Nucleobases and Amino Acids

The conditions that led to the formation of the first organisms and the ways that life originates from a lifeless chemical soup are poorly understood. The recent hypothesis of “RNA-peptide coevolution” suggests that the current close relationship between amino acids and nucleobases may well have extended to the origin of life. We now show how the interplay between these compound classes can give rise to new self-replicating molecules using a dynamic combinatorial approach. We report two strategies for the fabrication of chimeric amino acid/nucleobase self-replicating macrocycles capable of exponential growth. The first one relies on mixing nucleobase-and peptide-based building blocks, where the ligation of these two gives rise to highly specific chimeric ring structures. The second one starts from peptide nucleic acid (PNA) building blocks in which nucleobases are already linked to amino acids from the start. While previously reported nucleic acid-based self-replicating systems rely on presynthesis of (short) oligonucleotide sequences, self-replication in the present systems start from units containing only a single nucleobase. Self-replication is accompanied by self-assembly, spontaneously giving rise to an ordered one-dimensional arrangement of nucleobase nanostructures.

PubMed Disclaimer

Conflict of interest statement.

Nanoparticles overcome drug-resistant cancer via sequential drug release and photothermal therapy

Cancer cells frequently develop the ability to expel anticancer drugs before they can work—a phenomenon called multidrug resistance (MDR)—which is one of the leading reasons why chemotherapy fails in patients. Research published in the Journal of Controlled Release addresses that problem with a fundamentally new strategy: instead of simply increasing drug doses or switching drugs, researchers engineered nanoparticles that first disable the cancer cell’s drug-expulsion mechanism, and only then release the anticancer drug.

By combining this sequential drug delivery approach with photothermal therapy (using near-infrared laser light to heat and destroy the tumor), complete tumor elimination and 100% survival in a mouse model of drug-resistant cancer were achieved, with no detectable toxicity to normal tissues.

This remarkable drug delivery system was developed by an international research team led by Professor Eijiro Miyako at Tohoku University, who is also a Visiting Professor at Japan Advanced Institute of Science and Technology, in collaboration with the group of Drs. Alberto Bianco and Cécilia Ménard-Moyon at the French National Center for Scientific Research (CNRS)/University of Strasbourg.

The “Nanobot” Singularity: Ray Kurzweil’s Terrifying Plan for 2030

👉 Get The AI Career Survival Guide: https://technomics.gumroad.com/l/ai-s

What if immortality and god-like intelligence were just a few years away?
Renowned futurist and former Google engineer Ray Kurzweil predicts that humanity is rapidly approaching a \.

In Vivo RNA Delivery to Hematopoietic Stem and Progenitor Cells via Targeted Lipid NanoparticlesClick to copy article linkArticle link copied!

A nicely concise paper on antibody-linked lipid nanoparticles which target hematopoietic stem and progenitor cells in vivo, important yet tricky cell types to transduce for hematological gene therapy.


Ex vivo autologous hematopoietic stem cell (HSC) gene therapy has provided new therapies for the treatment of hematological disorders. However, these therapies have several limitations owing to the manufacturing complexities and toxicity resulting from required conditioning regimens. Here, we developed a c-kit (CD117) antibody-targeted lipid nanoparticle (LNP) that, following a single intravenous injection, can deliver RNA (both siRNA and mRNA) to HSCs in vivo in rodents. This targeted delivery system does not require stem cell harvest, culture, or mobilization of HSCs to facilitate delivery. We also show that delivery of Cre recombinase mRNA at a dose of 1 mg kg–1 can facilitate gene editing to almost all (∼90%) hematopoietic stem and progenitor cells (HSPCs) in vivo, and edited cells retain their stemness and functionality to generate high levels of edited mature immune cells.

Scientists Uncover Hidden Property of Light That Twists Matter Sideways

The researchers confirmed this by designing experiments that removed angular momentum while preserving helicity. The sideways rotation still occurred, showing that helicity plays the key role.

This finding offers a deeper understanding of how light interacts with matter at extremely small scales. It also points to new ways of controlling nanoscale systems, with possible applications in light-driven nanomachines and advanced sensing technologies.

“This work represents a new measurement paradigm for nanoscale optomechanics,” says Tanaka. “Just as optical tweezers opened a new field in single-molecule biophysics, we hope this platform will unlock access to nanoscale mechanical phenomena that have so far remained beyond reach.”

Researchers combine five metals to build a better nanocrystal

A nanocrystal is an extraordinarily tiny piece of material—composed of anywhere from a few to a few thousand atoms—in which atoms are arranged in a precise, ordered structure. Think of it like taking a piece of gold and shrinking it down to the size of a few hundred atoms. It’s still gold, still crystalline, just almost incomprehensibly small.

Nanocrystals are in the transistors inside computers and smartphones, in smartphone displays and TV screens, in the gold-nanoparticle sensors that power COVID and pregnancy tests, and in the pipes of your car exhaust system, among countless other innovations.

Their small size gives them a dramatically higher ratio of surface area to volume, making them especially useful as catalysts—materials that speed up chemical reactions without being consumed in the process.

Nanotechnology-Driven Therapeutic Innovations in Neurodegenerative Disorders: A Focus on Alzheimer’s and Parkinson’s Disease

Neurodegenerative disorders entail a progressive loss of neurons in cerebral and peripheral tissues, coupled with the aggregation of proteins exhibiting altered physicochemical properties. Crucial to these conditions is the gradual degradation of the central nervous system, manifesting as impairments in mobility, aberrant behaviors, and cognitive deficits. Mechanisms such as proteotoxic stress, neuroinflammation, oxidative stress, and programmed cell death contribute to the ongoing dysfunction and demise of neurons. Presently, neurodegenerative diseases lack definitive cures, and available therapies primarily offer palliative relief. The integration of nanotechnology into medical practices has significantly augmented both treatment efficacy and diagnostic capabilities.

When “Artificial Neurons” Can Talk Directly to the “Brain”

*** This content was analyzed and written by AI for informational purposes only.
*** Please consult a specialist for professional advice.

The world is entering an era where “technology” and “living organisms” merge into one. Most recently, in 2026, a research team from Northwestern University created a landmark breakthrough by developing “Printed Neurons.” These are not designed just to mimic biology—they can actually “transmit signals” to communicate with living brain cells!

Why is this a big deal?
Typically, the silicon-based computers we use today operate entirely differently from the human brain. Computers consume massive amounts of power and are rigid. In contrast, our brains use only about 20 watts (less than some lightbulbs) and are incredibly flexible.
Creating artificial neurons that “speak the same language as the brain” is the key to treating diseases that were once considered incurable.

Innovations in “Electronic Ink” and “3D Printing“
At the heart of this research lies a leap forward in materials science and engineering:
• Nanomaterials (MoS₂ and Graphene): Researchers used these materials to create a specialized “ink” for printing neural networks. These materials are unique for being both flexible and excellent conductors of electricity.
• Aerosol Jet Printing: This technology allows for nano-level precision printing on flexible plastic sheets, designed to contour perfectly to human tissue.
• Biomimicry: These artificial cells can generate electrical signals called “Spikes,” matching the rhythm and speed of actual biological neurons.

Proven! Successful Communication with a “Mouse Brain“
The research team tested the connection between these printed neurons and mouse brain tissue. The results showed that the mouse brain cells could receive and respond to signals from the artificial device as if they were from their own kind. This is vital evidence that humans can create devices that interface seamlessly with the nervous system.

Printed Neurons Just Talked to Living Brain Cells

Printed artificial neurons reported by Northwestern University can produce neuron-like electrical spikes and trigger responses in living mouse brain tissue. This video explains what was shown, why it matters for brain-like computing and future neural interfaces, and why it is still early laboratory research, not a human implant.

Sources:
Northwestern Now: https://news.northwestern.edu/stories

  • Nature Nanotechnology: https://www.nature.com/natnanotech/
  • Subscribe for clear, cinematic science stories in about five minutes.
    Nature Nanotechnology: https://www.nature.com/natnanotech/

    Subscribe for clear, cinematic science stories in about five minutes.

    New DNA-Based Therapy Can Help Lower ‘Bad Cholesterol’ Without Statins, Finds Study

    Scientists may have found a powerful new way to lower “bad” cholesterol, which did not involve the use of statin medicines. In a recent study, researchers used tiny DNA-based molecules to cut levels of LDL (bad) cholesterol by nearly 50% in animal models. This was done without the side effects that are often linked to statins. If these results stay consistent in large human trials, the therapy could become an important option for people who cannot tolerate statins or who still have high cholesterol despite taking them. The study was led by Carles J. Ciudad and Veronica Noe from the University of Barcelona’s Faculty of Pharmacy and Food Sciences and the Institute of Nanoscience and Nanotechnology (IN2UB), working with Nathalie Pamir at the University of Oregon in Portland (United States). It was published in the journal Biochemical Pharmacology.

    High LDL cholesterol is one of the biggest risk factors for heart attacks and strokes because it leads to the build up fatty plaques in arteries. Drugs like statins work well for many, but some people suffer from muscle aches, digestive issues, or liver problems and have to stop them. However, the new approach is different. Instead of changing how the liver handles fats, it targets a specific protein in the blood that controls how much LDL stays circulating.

    /* */